Amphetamine Stimulates Endocytosis of the Norepinephrine and Neuronal Glutamate Transporters in Cultured Locus Coeruleus Neurons

• Published in: Neurochemical research Vol. 45; no. 6; pp. 1410 - 1419
• Main Authors: Underhill, Suzanne M., Colt, Mark S., Amara, Susan G.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.06.2020; Springer Nature B.V
• Subjects: Activation; Adrenergic Uptake Inhibitors - pharmacology; Amines; Amino Acid Transport System X-AG - metabolism; Amphetamine - pharmacology; Amphetamines; Animals; Biochemistry; Biogenic amines; Biomedical and Life Sciences; Biomedicine; Ca2+/calmodulin-dependent protein kinase II; Calcium; Calcium (intracellular); Catecholamines; Cell Biology; Dopamine; Dopamine transporter; Dopamine Uptake Inhibitors - pharmacology; Dopaminergic Neurons - drug effects; Dopaminergic Neurons - metabolism; Endocytosis; Endocytosis - drug effects; Endocytosis - physiology; Excitatory Amino Acid Transporter 3 - metabolism; Glutamatergic transmission; Glutamic acid transporter; Guanosine triphosphatases; HEK293 Cells; Humans; Internalization; Intracellular; Locus coeruleus; Locus Coeruleus - drug effects; Locus Coeruleus - metabolism; Mice; Neurochemistry; Neurology; Neurons; Neurosciences; Neurotransmitters; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins - metabolism; Norepinephrine transporter; Original Paper; Potentiation; RhoA protein; Signaling; Norepinephrine; NET; TAAR1; RhoA; Locus coeruleus; EAAT3
• ISSN: 0364-3190; 1573-6903
• DOI: 10.1007/s11064-019-02939-6

Amphetamines and amphetamine-derivatives elevate neurotransmitter concentrations by competing with endogenous biogenic amines for reuptake. In addition, AMPHs have been shown to activate endocytosis of the dopamine transporter (DAT) which further elevates extracellular dopamine (DA). We previously found that the biochemical cascade leading to this cellular process involves entry of AMPH into the cell through the DAT, stimulation of an intracellular trace amine-associated receptor, TAAR1, and activation of the small GTPase, RhoA. We also showed that the neuronal glutamate transporter, EAAT3, undergoes endocytosis via the same cascade in DA neurons, leading to potentiation of glutamatergic inputs. Since AMPH is a transported inhibitor of both DAT and the norepinephrine transporter (NET), and EAAT3 is also expressed in norepinephrine (NE) neurons, we explored the possibility that this signaling cascade occurs in NE neurons. We found that AMPH can cause endocytosis of NET as well as EAAT3 in NE neurons. NET endocytosis is dependent on TAAR1, RhoA, intracellular calcium and CaMKII activation, similar to DAT. However, EAAT3 endocytosis is similar in all regards except its dependence upon CaMKII activation. RhoA activation is dependent on calcium, but not CaMKII, explaining a divergence in AMPH-mediated endocytosis of DAT and NET from that of EAAT3. These data indicate that AMPHs and other TAAR1 agonists can affect glutamate signaling through internalization of EAAT3 in NE as well as DA neurons.